Literature DB >> 1415569

Angiotensin II receptor subtypes in cultured rat renal mesangial cells.

P Ernsberger1, J Zhou, T H Damon, J G Douglas.   

Abstract

The selective angiotensin (ANG II) antagonists losartan (DuP 753) and PD 123319 have been shown to bind selectively to AT1 and AT2 subtypes, respectively. To characterize ANG II receptor subtypes in mesangial cells, washed membranes were incubated with 0.1 to 0.5 nM 125I-ANG II and increasing concentrations of competitors. The inhibition of 125I-ANG II binding by losartan and PD 123319 was biphasic, and LIGAND curve-fitting analysis revealed two populations of specific binding sites. One subpopulation comprised 86% of the total and showed high affinity for ANG II and losartan, but low affinity for the AT2 antagonists PD 123319 and CGP42112A, and thus appear identical to the recently cloned AT1 subtype. The remaining 14% of the sites showed nearly 100-fold lower affinity for losartan and 10,000-fold higher affinity for PD 123319 relative to AT1 sites. However, another AT2-selective antagonist, CGP42112A, showed little affinity for these sites. Both classes of binding sites were inhibited by guanosine 5'-O-(3-thiophosphate) and pertussis toxin treatment. We propose that there are two distinct G protein-coupled ANG II receptor subtypes (AT1A and AT1B) present in renal mesangial cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415569     DOI: 10.1152/ajprenal.1992.263.3.F411

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [³H]dopamine and [³H]norepinephrine release.

Authors:  Vidya Narayanaswami; Sucharita S Somkuwar; David B Horton; Lisa A Cassis; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2013-07-04       Impact factor: 5.858

2.  Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.

Authors:  S L Cox; D F Story; J Ziogas
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat.

Authors:  S L Cox; D F Story; J Ziogas
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.

Authors:  H M Siragy; R M Carey
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

5.  The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.

Authors:  H M Siragy; R M Carey
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

6.  Natriuretic action of angiotensin(1-7).

Authors:  A M DelliPizzi; S D Hilchey; C P Bell-Quilley
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

7.  A pharmacological differentiation between postjunctional (AT1A) and prejunctional (AT1B) angiotensin II receptors in the rabbit aorta.

Authors:  Serafim Guimarães; Catarina Carneiro; Fernando Brandão; Helder Pinheiro; António Albino-Teixeira; Daniel Moura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-23       Impact factor: 3.000

8.  Role of the angiotensin II type-2 receptor in radiation nephropathy.

Authors:  Eric P Cohen; Brian L Fish; Mukut Sharma; X Allen Li; John E Moulder
Journal:  Transl Res       Date:  2007-05-25       Impact factor: 7.012

9.  Arachidonic acid mediates angiotensin II effects on p21ras in renal proximal tubular cells via the tyrosine kinase-Shc-Grb2-Sos pathway.

Authors:  H Jiao; X L Cui; M Torti; C H Chang; L D Alexander; E G Lapetina; J G Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

10.  Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.

Authors:  V Briand; L Riva; A M Galzin
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.